Final Thoughts Peptides are natures micro-messengers, designed to spark healing and repair in specific ways
International scheduling Australia's Therapeutic Goods Administration (interim decision, April 2024) and New Zealand's Medsafe (Medicines Classification Committee, June 2025) have moved to schedule BPC-157 as a prescription-only medicine, despite its unavailability through legitimate prescription
Understanding who benefits most helps you determine whether this specific formulation matches your situation
Wang Z, Weitzmann MN, Sangadala S, Hutton WC, Yoon ST
Given the heterogeneity of breast cancer and the complexity of angiogenesis, it is unlikely that the identification of a single target such as VEGF would be adequate in the treatment of this disease